| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/18/2023 | 429.8% | HC Wainwright & Co. | → $8 | Reiterates | Buy → Buy |
| 06/26/2023 | 429.8% | HC Wainwright & Co. | → $8 | Reiterates | Buy → Buy |
| 06/06/2023 | 429.8% | HC Wainwright & Co. | → $8 | Reiterates | → Buy |
| 05/09/2023 | 429.8% | HC Wainwright & Co. | $20 → $8 | Maintains | Buy |
| 08/18/2020 | 1224.5% | HC Wainwright & Co. | $19 → $20 | Maintains | Buy |
| 01/13/2020 | 1621.85% | HC Wainwright & Co. | $12 → $26 | Reiterates | → Buy |
| 12/24/2019 | 694.7% | HC Wainwright & Co. | $10 → $12 | Reiterates | → Buy |
| 07/22/2019 | 562.25% | HC Wainwright & Co. | → $10 | Initiates Coverage On | → Buy |
| 11/19/2018 | — | Ladenburg Thalmann | Downgrades | Buy → Neutral |
What is the target price for Microbot Medical (MBOT)?
The latest price target for Microbot Medical (NASDAQ: MBOT) was reported by HC Wainwright & Co. on October 18, 2023. The analyst firm set a price target for $8.00 expecting MBOT to rise to within 12 months (a possible 429.80% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Microbot Medical (MBOT)?
The latest analyst rating for Microbot Medical (NASDAQ: MBOT) was provided by HC Wainwright & Co., and Microbot Medical reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Microbot Medical (MBOT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Microbot Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Microbot Medical was filed on October 18, 2023 so you should expect the next rating to be made available sometime around October 18, 2024.
Is the Analyst Rating Microbot Medical (MBOT) correct?
While ratings are subjective and will change, the latest Microbot Medical (MBOT) rating was a reiterated with a price target of $0.00 to $8.00. The current price Microbot Medical (MBOT) is trading at is $1.51, which is within the analyst's predicted range.